Table 3. Multivariate analysis for type 2 endotype (defined as criterion No.1: IgE > 150 and/or BE > 300 and/or FeNO > 25) in severe asthmatic patients.
Variable | OR | 95% CI | P value | ||
---|---|---|---|---|---|
Sex (male vs. female) | 1.28 | 0.96–1.69 | 0.087 | ||
BMI (< 25 vs. ≥ 25) | 1.82 | 1.37–2.42 | 0.001 | ||
Age (yr) | |||||
41–60 vs. < 40 | 1.23 | 0.81–1.89 | 0.329 | ||
> 60 vs. < 40 | 1.69 | 1.08–2.65 | 0.022 | ||
Age of onset (vs. early < 12) | |||||
Intermediate (12–40) | 1.39 | 0.91–2.10 | 0.122 | ||
Late (> 40) | 1.89 | 1.17–3.04 | 0.009 | ||
(trend) | 0.008 |
IgE, immunoglobulin E; BE, blood eosinophils; FeNO, fractional exhaled nitric oxide; OR, odds ratio; CI, confidence interval; BMI, body mass index.